University of Illinois at Chicago Divisionof Hematology/Oncology — Chicago, Illinois

University of Illinois at Chicago Divisionof Hematology/Oncology is a clinical research site located in Chicago, Illinois, United States.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

University of Illinois at Chicago Divisionof Hematology/Oncology has participated in 1 clinical trials.

Therapeutic areas: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois at Chicago Divisionof Hematology/Oncology?

University of Illinois at Chicago Divisionof Hematology/Oncology has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois at Chicago Divisionof Hematology/Oncology conducted?

University of Illinois at Chicago Divisionof Hematology/Oncology has 1 clinical trials on record. Their work covers Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome.

Is University of Illinois at Chicago Divisionof Hematology/Oncology accredited by Crixeo Health?

University of Illinois at Chicago Divisionof Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Illinois at Chicago Divisionof Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.